Y Intercept (Hong Kong) LTD Maravai Lifesciences Holdings, Inc. Transaction History

Y Intercept (Hong Kong) LTD

$1.27 Billion
Q1 2024

A detailed history of Y Intercept (Hong Kong) LTD transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 99,813 shares of MRVI stock, worth $714,661. This represents 0.07% of its overall portfolio holdings.

Number of Shares

99,813

Previous 57,306 74.18%

Holding current value

$714,661

Previous $375,000 130.67%

% of portfolio

0.07%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.11 - $8.76 $217,210 - $372,361	42,507 Added 74.18%	99,813 $865,000
Q4 2023 Feb 13, 2024	BUY	$4.7 - $9.87 $158,916 - $333,724	33,812 Added 143.92%	57,306 $375,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $214,735 - $301,897	23,494 New	23,494 $234,000
Q1 2023 May 09, 2023	SELL	$12.99 - $16.48 $40,476 - $51,351	-3,116 Reduced 5.86%	50,060 $701,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $447,812 - $887,743	35,825 Added 206.47%	53,176 $760,000

Q2 2022 Aug 08, 2022	BUY	$26.05 - $37.48 $249,975 - $359,658	9,596 Added 123.74%	17,351 $493,000
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $189,687 - $317,334	7,755 New	7,755 $274,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $357,560 - $469,323	-10,216 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $65,724 - $108,267	1,786 Added 21.19%	10,216 $501,000
Q2 2021 Aug 26, 2021	BUY	$32.46 - $45.0 $273,637 - $379,350	8,430 New	8,430 $352,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $45.0 $0 - $0	0 New	0 $352,000

Others Institutions Holding MRVI

# of Institutions

226

Shares Held

135M

Call Options Held

339K

Put Options Held

148K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $942M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Account

Y Intercept (Hong Kong) LTD Maravai Lifesciences Holdings, Inc. Transaction History